Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))

Thanapon Songthammawat; Tayanan Srisupa-Olan; Sasitorn Siritho; Kulvara Kittisares; Jiraporn Jitprapaikulsan; Chanjira Sathukitchai; Naraporn Prayoonwiwat

doi:10.1016/j.msard.2024.106233

Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))

Thanapon Songthammawat, Tayanan Srisupa-Olan, Sasitorn Siritho, Kulvara Kittisares, Jiraporn Jitprapaikulsan, Chanjira Sathukitchai, Naraporn Prayoonwiwat

Research output: Contribution to journal › Comment/debate

Abstract

The authors would like to thank the funding resource as below. Acknowledgments The authors are grateful for the funding resource. This research project is supported by Mahidol University.

Original language	English
Article number	106233
Journal	Multiple Sclerosis and Related Disorders
Volume	93
DOIs	https://doi.org/10.1016/j.msard.2024.106233
Publication status	Published - Jan 2025

Access to Document

10.1016/j.msard.2024.106233

Fingerprint

Dive into the research topics of 'Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))'. Together they form a unique fingerprint.

Cite this

Songthammawat, T., Srisupa-Olan, T., Siritho, S., Kittisares, K., Jitprapaikulsan, J., Sathukitchai, C., & Prayoonwiwat, N. (2025). Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506)). Multiple Sclerosis and Related Disorders, 93, Article 106233. https://doi.org/10.1016/j.msard.2024.106233

Songthammawat, Thanapon ; Srisupa-Olan, Tayanan ; Siritho, Sasitorn et al. / Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders : Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506)). In: Multiple Sclerosis and Related Disorders. 2025 ; Vol. 93.

@article{a71a0778e828422bab35b21e2ceec2af,

title = "Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))",

abstract = "The authors would like to thank the funding resource as below. Acknowledgments The authors are grateful for the funding resource. This research project is supported by Mahidol University.",

author = "Thanapon Songthammawat and Tayanan Srisupa-Olan and Sasitorn Siritho and Kulvara Kittisares and Jiraporn Jitprapaikulsan and Chanjira Sathukitchai and Naraporn Prayoonwiwat",

note = "Publisher Copyright: {\textcopyright} 2024 Elsevier B.V.",

year = "2025",

month = jan,

doi = "10.1016/j.msard.2024.106233",

language = "English",

volume = "93",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier B.V.",

}

Songthammawat, T, Srisupa-Olan, T, Siritho, S, Kittisares, K , Jitprapaikulsan, J, Sathukitchai, C & Prayoonwiwat, N 2025, 'Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))', Multiple Sclerosis and Related Disorders, vol. 93, 106233. https://doi.org/10.1016/j.msard.2024.106233

Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506)). / Songthammawat, Thanapon; Srisupa-Olan, Tayanan; Siritho, Sasitorn et al.
In: Multiple Sclerosis and Related Disorders, Vol. 93, 106233, 01.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders

T2 - Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))

AU - Songthammawat, Thanapon

AU - Srisupa-Olan, Tayanan

AU - Siritho, Sasitorn

AU - Kittisares, Kulvara

AU - Jitprapaikulsan, Jiraporn

AU - Sathukitchai, Chanjira

AU - Prayoonwiwat, Naraporn

PY - 2025/1

Y1 - 2025/1

N2 - The authors would like to thank the funding resource as below. Acknowledgments The authors are grateful for the funding resource. This research project is supported by Mahidol University.

AB - The authors would like to thank the funding resource as below. Acknowledgments The authors are grateful for the funding resource. This research project is supported by Mahidol University.

UR - http://www.scopus.com/inward/record.url?scp=85212589933&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2024.106233

DO - 10.1016/j.msard.2024.106233

M3 - Comment/debate

AN - SCOPUS:85212589933

SN - 2211-0348

VL - 93

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

M1 - 106233

ER -

Songthammawat T, Srisupa-Olan T, Siritho S, Kittisares K , Jitprapaikulsan J, Sathukitchai C et al. Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506)). Multiple Sclerosis and Related Disorders. 2025 Jan;93:106233. doi: 10.1016/j.msard.2024.106233

Abstract

Access to Document

Other files and links

Fingerprint

Cite this